Table 1.
Demographics
| Variable | Mean ± SD (range) or % |
|---|---|
| Age (y) | 34.5 ± 7.4 |
| BMI (kg/m2) | 25.3 ± 5.7 |
| Severity of deep dyspareunia (0–10) | 5.9 ± 3.2 (0–10) |
| New referral vs re-referral | 76 (416/548) vs 24 (132/548) |
| Endometriosis | |
| Prior surgical diagnosis | 54 (293/548) |
| Clinically suspected | 16 (88/548) |
| Excluded | 30 (167/548) |
| Stage (if prior surgical diagnosis) | |
| I–II | 44 (128/293) |
| III–IV | 45 (133/293) |
| Unknown∗ | 11 (32/293) |
| Cul-de-sac or uterosacral nodule at current examination | 11 (62/548) |
| Currently on hormonal suppression | 37 (204/548) |
| Previous laparoscopies, median (range) | 1 (0–14) |
| Currently taking neuromodulator (pain adjuvant) | 22 (123/548) |
| Painful bladder syndrome | 42 (230/548) |
| Currently on Elmiron† | 3 (6/230) |
| Irritable bowel syndrome | 53 (290/548) |
| Ethnicity (Caucasian) | 75 (403/536) |
| Sexual orientation (heterosexual) | 95 (498/535) |
| Marital status (married) | 46 (247/534) |
| Previous pregnancy | 49 (264/534) |
| Currently employed | 75 (399/534) |
| Education level, median | 2 y of college |
| Income, median (range) | $60,000–$79,000 |
| Current smoking | 13 (71/534) |
| Current drug use | 11 (59/530) |
BMI = body mass index.
∗
Unable to determine from operative note.
†
Pentosan polysulfate sodium (Janssen Pharmaceuticals, Titusville, NJ, USA).